UPDATE : Thursday, September 12, 2019
GSK’s chronic hand eczema treatment faces local competition by Lee Han-soo 2019-09-12 07:22
Chong Kun Dang wins patent suit against Novartis over immunosuppressant by Jeong Sae-im 2019-09-11 15:16
AstraZeneca to challenge Roche in small-cell lung cancer treatment market by Kim Yun-mi 2019-09-11 14:18
Amgen fetes 1st anniversary of getting expanded indication for Repatha by Lee Han-soo 2019-09-11 13:56
Hanmi to launch 3-substance combination in Latin America by Lee Han-soo 2019-09-11 13:56
Daewoong to test botulinum toxin Nabota for hair loss by Jeong Sae-im 2019-09-11 13:56
Novartis withdraws suit against Ahngook’s generic drug by Jeong Sae-im 2019-09-10 15:38
Immunotherapies Opdivo, Keytruda score high in real setting by Kim Eun-young 2019-09-10 12:49
'Xarelto has superior renal preservation benefits in atrial fibrillation patients’ by Lee Han-soo 2019-09-09 16:54
Hanmi to unveil investigator-led P2 progress for cancer treatment by Lee Han-soo 2019-09-09 15:47
Novo Nordisk's Ryzodeg leads Korean mixed insulin market by Lee Han-soo 2019-09-09 14:18
PARP inhibitors to show intense rivalry at ESMO 2019 by Kim Yun-mi 2019-09-09 11:56
Ildong to sell GSK’s influenza treatment by Lee Han-soo 2019-09-06 17:02
Yuhan to expand biz scope to central nervous system disease by Jeong Sae-im 2019-09-06 14:56
Seoul Pharmaceutical to export erectile dysfunction treatment to Taiwan by Lee Han-soo 2019-09-05 17:04
Lilly’s migraine treatment Emgality lands in Korea by Lee Hye-seon 2019-09-05 16:24
Daewoong, Medytox squabble over appraisal of additional spore for Nabota by Lee Han-soo 2019-09-05 14:35
[News analysis] Takeda Korea’s merger with Shire has to surmount big hurdle; labor union by Lee Han-soo 2019-09-04 17:06
JW Pharmaceutical acquires Vietnamese drugmaker by Lee Han-soo 2019-09-04 15:16
Takeda Korea vows to release 16 new drugs by 2023 by Kim Yun-mi 2019-09-03 15:40
Back to Top